dr. palakurthi on strategies for managing resistance to osimertinib in patients with nsclc
Published 8 years ago • 30 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
1:37
sangeetha palakurthi on strategies for managing resistance to osimertinib in patients with nsclc
-
1:16
dr. goldberg on options after developing resistance to osimertinib for nsclc
-
1:41
dr. goldberg on resistance to osimertinib for nsclc
-
1:33
dr. yang on resistance mechanisms from osimertinib in nsclc
-
1:03
sangeetha palakurthi on fda approval of atezolizumab in nsclc
-
1:05
dr. ramalingam on the activity of osimertinib combinations in nsclc
-
7:45
upfront use of osimertinib in egfr nsclc
-
1:31
dr. gold on the future of osimertinib in lung cancer
-
2:00
dr. goldberg on sequencing following treatment with osimertinib in nsclc
-
5:29
osimertinib for the t790m resistance mutation
-
3:17
osimertinib in egfr-positive nsclc with brain metastases
-
2:04
dr. suresh ramalingam on frontline osimertinib data in egfr nsclc
-
1:31
dr. oxnard on detecting resistance mechanisms after treatment with osimertinib
-
3:24
sequencing of therapies in egfr-mutant nsclc
-
2:05
dr. garassino discusses promising findings with osimertinib for patients with nsclc and brain mets
-
6:54
precision medicine and biologics hold the key to better therapeutic outcomes: dr c n ramchand
-
0:53
dr. perez-soler on impact of osimertinib on field of nsclc
-
0:21
when the patient says, “you too!” bad things happen! #shorts #surgeonlife
-
2:11
targeting recurrent glioblastoma: new therapy aims to improve survival